世界のムスカリン性アセチルコリン受容体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Muscarinic Acetylcholine Receptor Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3969
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ムスカリン性アセチルコリン受容体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（M1、M4、M5、その他）、用途別市場規模（注意欠陥多動性障害、精神障害、アルツハイマー病、慢性閉塞性肺疾患、記憶障害）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ムスカリン性アセチルコリン受容体の市場動向
・企業の競争状況、市場シェア
・ムスカリン性アセチルコリン受容体の種類別市場規模（M1、M4、M5、その他）
・ムスカリン性アセチルコリン受容体の用途別市場規模（注意欠陥多動性障害、精神障害、アルツハイマー病、慢性閉塞性肺疾患、記憶障害）
・ムスカリン性アセチルコリン受容体の北米市場規模2016-2027（アメリカ、カナダ）
・ムスカリン性アセチルコリン受容体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ムスカリン性アセチルコリン受容体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ムスカリン性アセチルコリン受容体の中南米市場規模2016-2027（メキシコ、ブラジル）
・ムスカリン性アセチルコリン受容体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Anavex Life Sciences Corp、AstraZeneca Plc、Heptares Therapeutics Ltd、Karuna Pharmaceuticals Inc、NeuroHealing Pharmaceuticals Inc、Sumitomo Dainippon Pharma Co Ltd）
・結論

Muscarinic Acetylcholine Receptor (m-g protein coupled Receptor) is an autoantibody in the serum of patients with myasthenia gravis.

Market Analysis and Insights: Global Muscarinic Acetylcholine Receptor Market
The global Muscarinic Acetylcholine Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Muscarinic Acetylcholine Receptor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Muscarinic Acetylcholine Receptor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Muscarinic Acetylcholine Receptor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Muscarinic Acetylcholine Receptor market.

Global Muscarinic Acetylcholine Receptor Scope and Market Size
Muscarinic Acetylcholine Receptor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Muscarinic Acetylcholine Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
M1
M4
M5
Others

Segment by Application
Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer’s Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Anavex Life Sciences Corp
AstraZeneca Plc
Heptares Therapeutics Ltd
Karuna Pharmaceuticals Inc
NeuroHealing Pharmaceuticals Inc
Sumitomo Dainippon Pharma Co Ltd

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Muscarinic Acetylcholine Receptor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 M1
1.2.3 M4
1.2.4 M5
1.2.5 Others
1.3 Market by Application
1.3.1 Global Muscarinic Acetylcholine Receptor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Attention Deficit Hyperactivity Disorder
1.3.3 Psychiatric Disorders
1.3.4 Alzheimer’s Disease
1.3.5 Chronic Obstructive Pulmonary Disease
1.3.6 Memory Impairment
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Muscarinic Acetylcholine Receptor Market Perspective (2016-2027)
2.2 Muscarinic Acetylcholine Receptor Growth Trends by Regions
2.2.1 Muscarinic Acetylcholine Receptor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Muscarinic Acetylcholine Receptor Historic Market Share by Regions (2016-2021)
2.2.3 Muscarinic Acetylcholine Receptor Forecasted Market Size by Regions (2022-2027)
2.3 Muscarinic Acetylcholine Receptor Industry Dynamic
2.3.1 Muscarinic Acetylcholine Receptor Market Trends
2.3.2 Muscarinic Acetylcholine Receptor Market Drivers
2.3.3 Muscarinic Acetylcholine Receptor Market Challenges
2.3.4 Muscarinic Acetylcholine Receptor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Muscarinic Acetylcholine Receptor Players by Revenue
3.1.1 Global Top Muscarinic Acetylcholine Receptor Players by Revenue (2016-2021)
3.1.2 Global Muscarinic Acetylcholine Receptor Revenue Market Share by Players (2016-2021)
3.2 Global Muscarinic Acetylcholine Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Muscarinic Acetylcholine Receptor Revenue
3.4 Global Muscarinic Acetylcholine Receptor Market Concentration Ratio
3.4.1 Global Muscarinic Acetylcholine Receptor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Muscarinic Acetylcholine Receptor Revenue in 2020
3.5 Muscarinic Acetylcholine Receptor Key Players Head office and Area Served
3.6 Key Players Muscarinic Acetylcholine Receptor Product Solution and Service
3.7 Date of Enter into Muscarinic Acetylcholine Receptor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Muscarinic Acetylcholine Receptor Breakdown Data by Type
4.1 Global Muscarinic Acetylcholine Receptor Historic Market Size by Type (2016-2021)
4.2 Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Type (2022-2027)

5 Muscarinic Acetylcholine Receptor Breakdown Data by Application
5.1 Global Muscarinic Acetylcholine Receptor Historic Market Size by Application (2016-2021)
5.2 Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Muscarinic Acetylcholine Receptor Market Size (2016-2027)
6.2 North America Muscarinic Acetylcholine Receptor Market Size by Type
6.2.1 North America Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021)
6.2.2 North America Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027)
6.2.3 North America Muscarinic Acetylcholine Receptor Market Size by Type (2016-2027)
6.3 North America Muscarinic Acetylcholine Receptor Market Size by Application
6.3.1 North America Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021)
6.3.2 North America Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027)
6.3.3 North America Muscarinic Acetylcholine Receptor Market Size by Application (2016-2027)
6.4 North America Muscarinic Acetylcholine Receptor Market Size by Country
6.4.1 North America Muscarinic Acetylcholine Receptor Market Size by Country (2016-2021)
6.4.2 North America Muscarinic Acetylcholine Receptor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Muscarinic Acetylcholine Receptor Market Size (2016-2027)
7.2 Europe Muscarinic Acetylcholine Receptor Market Size by Type
7.2.1 Europe Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021)
7.2.2 Europe Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027)
7.2.3 Europe Muscarinic Acetylcholine Receptor Market Size by Type (2016-2027)
7.3 Europe Muscarinic Acetylcholine Receptor Market Size by Application
7.3.1 Europe Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021)
7.3.2 Europe Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027)
7.3.3 Europe Muscarinic Acetylcholine Receptor Market Size by Application (2016-2027)
7.4 Europe Muscarinic Acetylcholine Receptor Market Size by Country
7.4.1 Europe Muscarinic Acetylcholine Receptor Market Size by Country (2016-2021)
7.4.2 Europe Muscarinic Acetylcholine Receptor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size (2016-2027)
8.2 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Type
8.2.1 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Type (2016-2027)
8.3 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Application
8.3.1 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Application (2016-2027)
8.4 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Region
8.4.1 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Muscarinic Acetylcholine Receptor Market Size (2016-2027)
9.2 Latin America Muscarinic Acetylcholine Receptor Market Size by Type
9.2.1 Latin America Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021)
9.2.2 Latin America Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027)
9.2.3 Latin America Muscarinic Acetylcholine Receptor Market Size by Type (2016-2027)
9.3 Latin America Muscarinic Acetylcholine Receptor Market Size by Application
9.3.1 Latin America Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021)
9.3.2 Latin America Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027)
9.3.3 Latin America Muscarinic Acetylcholine Receptor Market Size by Application (2016-2027)
9.4 Latin America Muscarinic Acetylcholine Receptor Market Size by Country
9.4.1 Latin America Muscarinic Acetylcholine Receptor Market Size by Country (2016-2021)
9.4.2 Latin America Muscarinic Acetylcholine Receptor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size (2016-2027)
10.2 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Type
10.2.1 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Type (2016-2027)
10.3 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Application
10.3.1 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Application (2016-2027)
10.4 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Country
10.4.1 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Anavex Life Sciences Corp
11.1.1 Anavex Life Sciences Corp Company Details
11.1.2 Anavex Life Sciences Corp Business Overview
11.1.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Introduction
11.1.4 Anavex Life Sciences Corp Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021)
11.1.5 Anavex Life Sciences Corp Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor Introduction
11.2.4 AstraZeneca Plc Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 Heptares Therapeutics Ltd
11.3.1 Heptares Therapeutics Ltd Company Details
11.3.2 Heptares Therapeutics Ltd Business Overview
11.3.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Introduction
11.3.4 Heptares Therapeutics Ltd Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021)
11.3.5 Heptares Therapeutics Ltd Recent Development
11.4 Karuna Pharmaceuticals Inc
11.4.1 Karuna Pharmaceuticals Inc Company Details
11.4.2 Karuna Pharmaceuticals Inc Business Overview
11.4.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Introduction
11.4.4 Karuna Pharmaceuticals Inc Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021)
11.4.5 Karuna Pharmaceuticals Inc Recent Development
11.5 NeuroHealing Pharmaceuticals Inc
11.5.1 NeuroHealing Pharmaceuticals Inc Company Details
11.5.2 NeuroHealing Pharmaceuticals Inc Business Overview
11.5.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Introduction
11.5.4 NeuroHealing Pharmaceuticals Inc Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021)
11.5.5 NeuroHealing Pharmaceuticals Inc Recent Development
11.6 Sumitomo Dainippon Pharma Co Ltd
11.6.1 Sumitomo Dainippon Pharma Co Ltd Company Details
11.6.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
11.6.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Introduction
11.6.4 Sumitomo Dainippon Pharma Co Ltd Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021)
11.6.5 Sumitomo Dainippon Pharma Co Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Muscarinic Acetylcholine Receptor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of M1
Table 3. Key Players of M4
Table 4. Key Players of M5
Table 5. Key Players of Others
Table 6. Global Muscarinic Acetylcholine Receptor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Muscarinic Acetylcholine Receptor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Muscarinic Acetylcholine Receptor Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Muscarinic Acetylcholine Receptor Market Share by Regions (2016-2021)
Table 10. Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Muscarinic Acetylcholine Receptor Market Share by Regions (2022-2027)
Table 12. Muscarinic Acetylcholine Receptor Market Trends
Table 13. Muscarinic Acetylcholine Receptor Market Drivers
Table 14. Muscarinic Acetylcholine Receptor Market Challenges
Table 15. Muscarinic Acetylcholine Receptor Market Restraints
Table 16. Global Muscarinic Acetylcholine Receptor Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Muscarinic Acetylcholine Receptor Market Share by Players (2016-2021)
Table 18. Global Top Muscarinic Acetylcholine Receptor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muscarinic Acetylcholine Receptor as of 2020)
Table 19. Ranking of Global Top Muscarinic Acetylcholine Receptor Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Muscarinic Acetylcholine Receptor Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Muscarinic Acetylcholine Receptor Product Solution and Service
Table 23. Date of Enter into Muscarinic Acetylcholine Receptor Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Type (2016-2021)
Table 27. Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Muscarinic Acetylcholine Receptor Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Application (2016-2021)
Table 31. Global Muscarinic Acetylcholine Receptor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Muscarinic Acetylcholine Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Muscarinic Acetylcholine Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Muscarinic Acetylcholine Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Muscarinic Acetylcholine Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Muscarinic Acetylcholine Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Muscarinic Acetylcholine Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 63. Anavex Life Sciences Corp Company Details
Table 64. Anavex Life Sciences Corp Business Overview
Table 65. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Product
Table 66. Anavex Life Sciences Corp Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021) & (US$ Million)
Table 67. Anavex Life Sciences Corp Recent Development
Table 68. AstraZeneca Plc Company Details
Table 69. AstraZeneca Plc Business Overview
Table 70. AstraZeneca Plc Muscarinic Acetylcholine Receptor Product
Table 71. AstraZeneca Plc Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Plc Recent Development
Table 73. Heptares Therapeutics Ltd Company Details
Table 74. Heptares Therapeutics Ltd Business Overview
Table 75. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Product
Table 76. Heptares Therapeutics Ltd Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021) & (US$ Million)
Table 77. Heptares Therapeutics Ltd Recent Development
Table 78. Karuna Pharmaceuticals Inc Company Details
Table 79. Karuna Pharmaceuticals Inc Business Overview
Table 80. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product
Table 81. Karuna Pharmaceuticals Inc Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021) & (US$ Million)
Table 82. Karuna Pharmaceuticals Inc Recent Development
Table 83. NeuroHealing Pharmaceuticals Inc Company Details
Table 84. NeuroHealing Pharmaceuticals Inc Business Overview
Table 85. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product
Table 86. NeuroHealing Pharmaceuticals Inc Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021) & (US$ Million)
Table 87. NeuroHealing Pharmaceuticals Inc Recent Development
Table 88. Sumitomo Dainippon Pharma Co Ltd Company Details
Table 89. Sumitomo Dainippon Pharma Co Ltd Business Overview
Table 90. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Product
Table 91. Sumitomo Dainippon Pharma Co Ltd Revenue in Muscarinic Acetylcholine Receptor Business (2016-2021) & (US$ Million)
Table 92. Sumitomo Dainippon Pharma Co Ltd Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Muscarinic Acetylcholine Receptor Market Share by Type: 2020 VS 2027
Figure 2. M1 Features
Figure 3. M4 Features
Figure 4. M5 Features
Figure 5. Others Features
Figure 6. Global Muscarinic Acetylcholine Receptor Market Share by Application: 2020 VS 2027
Figure 7. Attention Deficit Hyperactivity Disorder Case Studies
Figure 8. Psychiatric Disorders Case Studies
Figure 9. Alzheimer's Disease Case Studies
Figure 10. Chronic Obstructive Pulmonary Disease Case Studies
Figure 11. Memory Impairment Case Studies
Figure 12. Muscarinic Acetylcholine Receptor Report Years Considered
Figure 13. Global Muscarinic Acetylcholine Receptor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Muscarinic Acetylcholine Receptor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Muscarinic Acetylcholine Receptor Market Share by Regions: 2020 VS 2027
Figure 16. Global Muscarinic Acetylcholine Receptor Market Share by Regions (2022-2027)
Figure 17. Global Muscarinic Acetylcholine Receptor Market Share by Players in 2020
Figure 18. Global Top Muscarinic Acetylcholine Receptor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muscarinic Acetylcholine Receptor as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Muscarinic Acetylcholine Receptor Revenue in 2020
Figure 20. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Type (2016-2021)
Figure 21. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Type (2022-2027)
Figure 22. North America Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Muscarinic Acetylcholine Receptor Market Share by Type (2016-2027)
Figure 24. North America Muscarinic Acetylcholine Receptor Market Share by Application (2016-2027)
Figure 25. North America Muscarinic Acetylcholine Receptor Market Share by Country (2016-2027)
Figure 26. United States Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Muscarinic Acetylcholine Receptor Market Share by Type (2016-2027)
Figure 30. Europe Muscarinic Acetylcholine Receptor Market Share by Application (2016-2027)
Figure 31. Europe Muscarinic Acetylcholine Receptor Market Share by Country (2016-2027)
Figure 32. Germany Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Muscarinic Acetylcholine Receptor Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Muscarinic Acetylcholine Receptor Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Muscarinic Acetylcholine Receptor Market Share by Region (2016-2027)
Figure 42. China Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Muscarinic Acetylcholine Receptor Market Share by Type (2016-2027)
Figure 50. Latin America Muscarinic Acetylcholine Receptor Market Share by Application (2016-2027)
Figure 51. Latin America Muscarinic Acetylcholine Receptor Market Share by Country (2016-2027)
Figure 52. Mexico Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Muscarinic Acetylcholine Receptor Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Muscarinic Acetylcholine Receptor Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Muscarinic Acetylcholine Receptor Market Share by Country (2016-2027)
Figure 58. Turkey Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Muscarinic Acetylcholine Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Anavex Life Sciences Corp Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2016-2021)
Figure 62. AstraZeneca Plc Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2016-2021)
Figure 63. Heptares Therapeutics Ltd Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2016-2021)
Figure 64. Karuna Pharmaceuticals Inc Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2016-2021)
Figure 65. NeuroHealing Pharmaceuticals Inc Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2016-2021)
Figure 66. Sumitomo Dainippon Pharma Co Ltd Revenue Growth Rate in Muscarinic Acetylcholine Receptor Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global 5 Hydroxytryptamine Receptor Blocker Market Size, Status and Forecast 2021-2027
QYR2104Z6159 2021年4月 86Pages
QYResearch社発行の本調査資料では、5ヒドロキシトリプタミン受容体遮断薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リゼルグ酸誘導体、シプロヘプタジン）、用途別市場規模（医療、科学研究、その他）、主要地域別市場規模（北米、アメリカ、...

世界のスフィンゴシン1-リン酸受容体（S1PR）モジュレーター市場規模・現状・予測（2021年-2027年）

Global Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market Size, Status and Forecast 2021-2027
QYR2104Z5393 2021年4月 94Pages
QYResearch社発行の本調査資料では、スフィンゴシン1-リン酸受容体（S1PR）モジュレーターのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（S1P1サブタイプ、S1P5サブタイプ）、用途別市場規模（成人RMS治療、RMS臨床症状追体験）...

世界の5-ヒドロキシトリプタミン受容体市場規模・現状・予測（2021年-2027年）

Global 5-Hydroxytryptamine Receptor Market Size, Status and Forecast 2021-2027
QYR2104Z6186 2021年4月 107Pages
QYResearch社発行の本調査資料では、5-ヒドロキシトリプタミン受容体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HTR6、HTR2B、その他）、用途別市場規模（注意欠陥多動性障害、精神障害、アルツハイマー病、慢性閉塞性肺疾患、記憶障...

世界のヒトFGFR3（線維芽細胞成長因子受容体）市場規模・現状・予測（2021年-2027年）

Global Human FGFR3(Fibroblast growth factor receptor) Market Size, Status and Forecast 2021-2027
QYR2104Z2945 2021年4月 90Pages
QYResearch社発行の本調査資料では、ヒトFGFR3（線維芽細胞成長因子受容体）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Hisタグ、Fcタグ）、用途別市場規模（ELISA、ウエスタンブロット、抗体産生、タンパク質アレイ）、主要地域...

世界の5-ヒドロキシトリプタミン受容体市場規模・現状・予測（2021年-2027年）

世界のGタンパク質共役型受容体市場規模・現状・予測（2021年-2027年）

Global G-protein Coupled Receptor Market Size, Status and Forecast 2021-2027
QYR2104Z2616 2021年4月 97Pages
QYResearch社発行の本調査資料では、Gタンパク質共役型受容体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カルシウムレベル検出アッセイ、GTPγS結合アッセイ、cGMPアッセイ、レポーター遺伝子アッセイ、受容体内在化アッセイ、cAMP...

世界の代謝型グルタミン酸受容体（MRG）市場 2021：企業別、地域別、種類・用途別

Global Metabotropic Glutamate Receptor (MRG) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z09124 2021年4月 103Pages
当調査資料では、代謝型グルタミン酸受容体（MRG）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。代謝型グルタミン酸受容体（MRG）の種類別市場規模（mGluR2、mGluR4、mGluR5）、用途別市場規模（髄膜炎、敗血症、その他）、地域別市場規模（...

世界のガンマアミノ酪酸（GABA）受容体市場 2021：企業別、地域別、種類・用途別

Global Gamma-Aminobutyric Acid (GABA) Receptor Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z06267 2021年4月 104Pages
当調査資料では、ガンマアミノ酪酸（GABA）受容体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ガンマアミノ酪酸（GABA）受容体の種類別市場規模（GABA-A受容体、GABA-B受容体）、用途別市場規模（注意欠陥多動性障害、精神障害、アルツハイマー...

世界のニューロペプチドY受容体市場 2021：企業別、地域別、種類・用途別

Global Neuropeptide Y Receptor Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z09920 2021年4月 101Pages
当調査資料では、ニューロペプチドY受容体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ニューロペプチドY受容体の種類別市場規模（食品用、医薬品用）、用途別市場規模（医薬品、食品添加物、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国...

世界のセロトニン受容体市場 2021：企業別、地域別、種類・用途別

Global Hydroxytryptamine Receptor Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z07384 2021年4月 108Pages
当調査資料では、セロトニン受容体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。セロトニン受容体の種類別市場規模（HTR6、HTR2B、その他）、用途別市場規模（注意欠陥多動性障害、精神障害、アルツハイマー病、慢性閉塞性肺疾患、記憶障害）、地域別市場規...

世界の注意欠陥多動性障害（ADHD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder Market The global Attention Deficit Hyperactivity Disorder market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
世界の5-ヒドロキシトリプタミン受容体市場規模・現状・予測（2021年-2027年） Serotonin receptors are a group of g-protein-coupled receptors and ligand gated ion channels that occur in the central and peripheral nervous system. They regulate both excitatory and inhibitory neurotransmitters. Market Analysis and Insights: Global 5-Hydroxytryptamine Receptor Market The global 5-…
世界の5-ヒドロキシトリプタミン受容体市場規模・現状・予測（2021年-2027年） Serotonin receptors are a group of g-protein-coupled receptors and ligand gated ion channels that occur in the central and peripheral nervous system. They regulate both excitatory and inhibitory neurotransmitters. Market Analysis and Insights: Global 5-Hydroxytryptamine Receptor Market The global 5-…
世界の注意欠陥多動性障害（ADHD）治療市場規模・現状・予測（2021年-2027年） Attention deficit hyperactivity disorder (ADHD) is a mental health disorder that can cause above-normal levels of hyperactive and impulsive behaviors. Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder Therapeutics Market The global Attention Deficit Hyperactivity Disorder…
世界の注意欠陥多動性障害（ADHD）治療市場規模・現状・予測（2021年-2027年） ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning. G…